ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 170 filers reported holding ANTARES PHARMA INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $129,000 | -0.8% | 31,299 | -14.2% | 0.00% | – |
| Q4 2021 | $130,000 | +66.7% | 36,468 | +70.5% | 0.00% | – |
| Q3 2021 | $78,000 | -58.7% | 21,393 | -50.6% | 0.00% | -100.0% |
| Q2 2021 | $189,000 | +4.4% | 43,305 | -1.4% | 0.00% | 0.0% |
| Q1 2021 | $181,000 | +24.8% | 43,922 | +20.6% | 0.00% | 0.0% |
| Q4 2020 | $145,000 | +168.5% | 36,408 | +80.7% | 0.00% | – |
| Q3 2020 | $54,000 | -11.5% | 20,145 | -9.8% | 0.00% | – |
| Q2 2020 | $61,000 | -40.8% | 22,337 | +1.9% | 0.00% | – |
| Q4 2019 | $103,000 | +66.1% | 21,926 | +19.0% | 0.00% | – |
| Q3 2019 | $62,000 | +24.0% | 18,424 | +20.5% | 0.00% | – |
| Q2 2019 | $50,000 | +4.2% | 15,295 | -2.6% | 0.00% | – |
| Q1 2019 | $48,000 | +17.1% | 15,697 | +3.2% | 0.00% | – |
| Q4 2018 | $41,000 | -30.5% | 15,209 | -13.9% | 0.00% | – |
| Q3 2018 | $59,000 | +20.4% | 17,661 | -7.1% | 0.00% | – |
| Q2 2018 | $49,000 | +22.5% | 19,017 | +3.5% | 0.00% | – |
| Q1 2018 | $40,000 | -4.8% | 18,367 | -13.9% | 0.00% | – |
| Q4 2017 | $42,000 | +2.4% | 21,332 | +68.0% | 0.00% | – |
| Q2 2017 | $41,000 | +156.2% | 12,695 | -33.0% | 0.00% | – |
| Q1 2016 | $16,000 | -40.7% | 18,943 | -15.9% | 0.00% | – |
| Q4 2015 | $27,000 | +8.0% | 22,527 | +52.7% | 0.00% | – |
| Q3 2015 | $25,000 | -39.0% | 14,751 | -24.5% | 0.00% | -100.0% |
| Q2 2015 | $41,000 | -32.8% | 19,529 | -13.4% | 0.00% | 0.0% |
| Q1 2015 | $61,000 | -4.7% | 22,555 | -10.0% | 0.00% | 0.0% |
| Q4 2014 | $64,000 | -24.7% | 25,068 | -45.9% | 0.00% | 0.0% |
| Q3 2014 | $85,000 | -44.1% | 46,372 | -18.5% | 0.00% | -50.0% |
| Q2 2014 | $152,000 | -62.0% | 56,889 | -50.2% | 0.00% | -60.0% |
| Q1 2014 | $400,000 | +38.4% | 114,149 | +60.3% | 0.01% | -28.6% |
| Q3 2013 | $289,000 | -0.3% | 71,209 | +2.3% | 0.01% | +16.7% |
| Q2 2013 | $290,000 | – | 69,629 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |